CD&R Investment Associates IX, Ltd. - 18 May 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role
10%+ Owner
Signature
CD&R Investment Associates IX, Ltd.; by Jillian C. Griffiths, Chief Financial Officer and Vice President
Issuer symbol
AGL
Transactions as of
18 May 2023
Net transactions value
-$1,958,937,549
Form type
4
Filing time
18 May 2023, 16:05:35 UTC
Previous filing
17 May 2023
Next filing
07 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Sale $1,958,937,549 -94,173,804 -48% $20.80 100,000,000 18 May 2023 By affiliate F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Following the transaction reported herein, CD&R Vector Holdings, L.P. ("CD&R Stockholder") directly owns 100,000,000 shares of the Issuer's Common Stock. CD&R Investment Associates IX, Ltd., as the general partner of CD&R Stockholder, may be deemed to beneficially own the shares of Common Stock held by CD&R Stockholder.
F2 CD&R Investment Associates IX, Ltd. expressly disclaims beneficial ownership of the shares of Common Stock held by CD&R Stockholder, except to the extent of its pecuniary interest therein.